Leading Biopharmaceutical Company Partners with Domino to Advance SCE

Domino Launches SCE Coalition with Leading Biopharmaceutical Customers and Launches Domino Flows and RevX: Life Sciences Edition to Help Transform the Clinical Analytics Field

San Francisco, May 28, 2024 /PRNewswire/ — Domino Data Labprovider of the leading enterprise AI platform trusted by leading AI-driven companies, today announced the launch of a new Statistical Computing Environment (SCE) coalition to overcome clinical research silos and accelerate the approval of new life-saving therapies, and introduced new platform capabilities for life sciences customers. Domino Flow,this week RevX: Life Sciences Edition.

Modern pharmaceutical R&D requires teams to adopt an open, cloud-based architecture for all data science and analytics work, with governance built in for quality and compliance. To achieve this, the SCE Coalition is convening experts from leading biopharmaceutical companies to build new workflows and methodologies that will transform the clinical analytics and SCE fields. Founding members of the Coalition include three of the top 10 pharmaceutical companies.

“We are incredibly proud to be able to help our customers bring life-saving therapies to market faster.” Nick Elprin“We are honored to be part of the SCE coalition and help accelerate innovation across the industry,” said Domino Data Lab CEO and co-founder.

Starting this week, Domino's will host ongoing SCE Coalition meetings to guide industry best practices, reimagine the future of clinical technology, and discuss business requirements for modernizing SCE in the AI ​​era.

The SCE Coalition's key focus areas are:

  • Workflow Management: It sets a new standard for fully GxP-compliant quality control (QC) workflows for clinical trial QC projects and tasks in a unified, traceable and accurate manner.
  • Reproducibility: Lower the barrier to demonstrating 100% reproducibility of statistical results, including all artifacts and dependencies, in accordance with health authority requirements.
  • Research Analysis: Develop new ways to further accelerate clinical trials by providing end users and decision makers with the key metrics they need to take action faster.

Accelerating Life Sciences Innovation with Integrated Solutions
The introduction of Domino Flows provides customers with new orchestration capabilities to automate complex, multi-step calculations and workflows at scale across the entire AI lifecycle. Built on Domino's flexible platform architecture, Flows accelerates statistical programming, computational life sciences and machine learning while responsibly orchestrating workflows and outputs with security, governance and regulatory compliance to accelerate time to value.

Within SCE, Flows helps accelerate clinical research with reliability and accountability, regardless of the size of the program, deliverables, or stakeholders. Flows enables clinical researchers to easily develop and run research programs across different languages, with complex dependencies between programs and datasets. Flows allows them to visualize these dependencies in a graph, run studies in an automated and reproducible manner, and ensure that all outputs are properly versioned and tied to the specific programs and people who created them.

In addition to Flows, Domino unveiled a suite of advanced platform capabilities designed to increase productivity and accelerate innovation for its life sciences customers.

  • Integrated Quality Control (QC) Goal Tracking It enables seamless, traceable management of clinical trials, increasing accountability and accelerating outcomes.
  • Improved Git integration interface It provides a more intuitive experience for statistical programmers, improves version control, and encourages innovation.
  • Next FuseThe Nextflow plugin, developed by KSM Technology Partners, enables efficient creation, execution, and monitoring of Nextflow bioinformatics pipelines with improved scalability and cost control.

RevX: Key Learnings for AI Leaders Driving Innovation in Life Sciences
Domino's also announced the lineup for RevX: Life Sciences Edition, the premier enterprise AI event tailored for data science and IT leaders in the biopharmaceutical space. May 30 At Convention Commerce Square PhiladelphiaThe event will focus on accelerating clinical applications, fostering innovation in preclinical research, and leveraging the latest advancements in data science, AI, and GenAI.

Participants will benefit from strategic insights and operational perspectives to rapidly and cost-effectively modernize their SCEs, and will gain practical templates and methodologies that can be applied immediately.

Notable speakers include:

  • Sol RashidiData & AI Strategy Advisor
  • Eileen ChinSenior Director, Biostatistical Technical Capability Delivery, GSK
  • Saurin MehtaSenior Director of Technology, GSK
  • Albert ParkSenior Director of Bioinformatics Engineering, Modena
  • Zeev KirielaDirector of Commercial Data Science and Head of AI/ML Products, Merck
  • Ronen ArtziOncology Data Science and AI, Technology Innovation Leader, AstraZeneca
  • Diya WinAI Leader, AWS
  • Michael HarnishPresident of KSM Technology Partners
  • Keith ParentCEO of Court Square Group
  • Nick ElprinCEO and co-founder of Domino's

Registration for this opportunity to learn from and network with pioneers shaping the future of enterprise AI in biopharma is currently open at: https://domino.ai/revx/Philadelphia

Dominoes for Clinical Research

Domino's unique approach to delivering SCE optimally uses cloud-native technology to balance the control and governance required for GxP while maintaining the flexibility essential to drive clinical trial efficiency. Domino is specifically designed to meet the rigorous compliance standards of the life sciences industry, providing automated reproducibility and auditability without compromising data access. This enables biopharmaceutical organizations to standardize and effectively unleash the power of data science and advanced analytics across the clinical trial lifecycle, ultimately accelerating time to market for new drugs and vaccines.


  • Domino Flows will be available in public preview in June.
  • Both Domino's integrated quality control (QC) goal tracking and simplified Git integration interface are available now.
  • Nextfuse is currently KSM Technology Partners.

Additional resources

About Domino Data Lab
Domino Data Lab helps the largest AI-driven enterprises build and operate AI at scale. Domino's enterprise AI platform combines the flexibility AI teams demand with the visibility and control enterprises need. Domino enables a repeatable, agile ML lifecycle to deliver the benefits of AI faster and more responsibly at a lower cost. Domino enables global enterprises to develop better medicines, grow more productive crops, develop more competitive products, and more. Founded in 2013, Domino is backed by leading investors including Sequoia Capital, Coatue Management, In-Q-Tel, NVIDIA, and Snowflake. Learn more here. Domino.

SOURCE Domino Data Lab

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *